According to Vision Research Reports, the global linear particle accelerators market size surpassed at US$ 2.7 Bn in 2020 and to reach US$ 4.9 billion by 2030 with a CAGR of 7% from 2021 to 2030.
Linear accelerator is used to deliver external beam radiation for the treatment of cancer. The LINAC system customizes high-energy electrons to take the shape of the tumor to be treated, and destroy cancerous cells without affecting the surrounding tissues. Healthcare professionals such as radiation oncologists work in collaboration with dosimetrists and physicians to decide over the radiation treatment plan and appropriate mode of radiation treatment to be delivered.
A LINAC system is programmed before each radiation therapy session to deliver high-energy X-rays. The radiation takes specific size & shape and tracks the location of a tumor. The system has built-in protective measures that are designed to prevent excess dosages delivered, which can be higher than the prescribed amount. Radiation therapists ensure that the intensity of radiation beam is constant by using a device called tracker.
In terms of type, the global linear particle accelerators market has been classified into low-energy machine, medium-energy machine, and high-energy machine. The low-energy machine segment captured the largest market share in 2019 and the trend is anticipated to continue during the forecast period. The segment is expected to be driven by increase in use of low-energy LINAC systems for treatment of breast cancer and rise in availability of low-energy LINAC systems. Based on end user, the global linear particle accelerators market has been categorized into hospitals, ambulatory care centers, and research centers. The hospitals segment held major share of the global market in 2019, owing to increase in installation of LINAC systems, demand for sophisticated treatment modalities for cancer, and use of linear accelerators for treatment of a broad range of tumors.
The increase in the global geriatric population is another factor driving the global linear particle accelerators market. According to Cancer Research U.K., people aged between 50 and 74 account for over half (53%) of all new cancer cases, with slightly more cases in males than females.
Production of New Linear Particle Accelerators to Decline amid COVID-19
The onset of the COVID-19 pandemic is anticipated to have a slight impact on the overall growth of the global linear particle accelerators market, particularly in 2020. Due to the dwindling demand from hospitals, ambulatory centers, and research centers amid the ongoing COVID-19 pandemic due to increasing focus on catering to the patients suffering from the novel of COVID-19 infection, the production of linear particle accelerators is likely to remain lower than the initial projections. However, on the research front, activities are likely to remain normal without any major interference from governments.
Research and Development Activities Offer Growth Opportunities
Research and development is expected to remain one of the most critical factors that will drive the growth of the global market for linear particle accelerators during the forecast period. With the onset of novel technologies and focus on automating the tuning process of the beam, scientists are exploring the possibilities of operating linear particle accelerators with a diminishing direction from humans. Several researchers and scientists are increasingly investing resources to automate various aspects of linear particle accelerators for the past two to three decades. Moreover, as per current trends, the next-generation of linear particle accelerators are likely to be highly automated– a factor that is expected to aid the growth of the global linear particle accelerators market in the upcoming decade.
Advancements in machine learning are increasingly being utilized for problem detection, optimizing beam lines, and create real-time simulations. At the back of these factors and other promising research outcomes, the global linear particle accelerators market is on the course to have a steady growth rate during the forecast period.
Demand for Linear Particle Accelerators to Treat Resistant Tumors on Rise
The number of ‘advanced’ cancer cases around the world has witnessed consistent growth in recent years, owing to a combination of both, poor lifestyle choices and genetic factors. Some of the conventional and popular cancer treatments, including chemotherapy and radiation have gained considerable popularity in the medical space over the past couple of decades. However, linear particle accelerators have emerged as one of the most promising alternative advanced treatments for resistant tumors and as per the current observations, the adoption is anticipated to witness a spike in the upcoming years. Research and development activities are expected to play a key role in the overall development of the global linear particle accelerators market during the forecast period. In recent years, medical experts around the world are increasing merging MRI with linear particle accelerators to improve the precision in cancer treatment– a factor that is anticipated to bolster the growth of the global linear particle accelerators market in stipulated timeframe of the study.
Prominent Regions
North America held a major share of the global linear particle accelerators market in 2019. Increase in demand for integrated treatment solutions in oncology and shift from the use of traditional radiation therapy to LINAC are the key factors driving the market in the region. Europe held the second largest share of the global linear particle accelerators market in 2019. The growth of the linear particle accelerators market in the region can be attributed to high adoption of newer technology systems and increase in incidence of breast cancer. According to Globocon, in 2018, Europe had 4,229,662 cancer cases. Breast cancer accounted for nearly 12.4% of newly diagnosed cases in 2018. Incidence of breast cancer was higher among women than in men. Colorectal cancer and lung cancer accounted for nearly 11.8% and 10.6% of newly diagnosed cases in the same year.
Key Players
Leading players are expanding their footprint to strengthen their positions in the global linear particle accelerators market. Development of innovative oncology systems, technological advancements, and geographic expansion by prominent market players are likely to present lucrative opportunities in the global linear particle accelerators market. Key players operating in the global linear particle accelerators market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Shinva Medical Instrument Co., Ltd., and Viewray Medical Technologies Inc.
Market Segmentation
By Type
By End User
By Region
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Linear Particle Accelerators Market Analysis and Forecast, 2018–2030
5. Key Insight
5.1. Technology Advancement
5.2. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (value chain and short /mid / long-term impact) Pricing Analysis
6. Global Linear Particle Accelerators Market Value (US$ Mn) and Volume (Units) Forecast, by Type
6.1. Introduction & Definition
6.2. Global Linear Particle Accelerators Market Value and Volume Forecast, by Type, 2018–2030
6.2.1. Low-energy Machine
6.2.2. Medium-energy Machine
6.2.3. High-energy Machine
6.3. Global Linear Particle Accelerators Market Attractiveness Analysis, by Type
7. Global Linear Particle Accelerators Market Value (US$ Mn) and Volume (Units) Forecast, by Product Type
7.1. Introduction & Definition
7.2. Global Linear Particle Accelerators Market Value and Volume Forecast, by Product Type, 2018–2030
7.2.1. X-Ray
7.2.2. Electron
7.2.3. Proton
7.2.4. Ion Beam
7.2.5. Others
7.3. Global Linear Particle Accelerators Market Attractiveness Analysis, by Product Type
8. Global Linear Particle Accelerators Market Value (US$ Mn) Forecast, by End-user
8.1. Introduction & Definition
8.2. Global Linear Particle Accelerators Market Value Forecast, by End-user, 2018–2030
8.2.1. Hospitals
8.2.2. Ambulatory Care Centers
8.2.3. Research Centers
8.3. Global Linear Particle Accelerators Market Attractiveness Analysis, by End-user
9. Global Linear Particle Accelerators Market Value (US$ Mn) Forecast, by Region
9.1. Introduction
9.2. Global Linear Particle Accelerators Market Value Forecast, by Region, 2018–2030
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Linear Particle Accelerators Market Attractiveness Analysis, by Region
10. North America Global Linear Particle Accelerators Market Analysis and Forecast
10.1. Introduction
10.2. North America Global Linear Particle Accelerators Market Value and Volume Forecast, by Type, 2018–2030
10.2.1. Low-energy Machine
10.2.2. Medium-energy Machine
10.2.3. High-energy Machine
10.3. North America Global Linear Particle Accelerators Market Value and Volume Forecast, by Product Type, 2018–2030
10.3.1. X-Ray
10.3.2. Electron
10.3.3. Proton
10.3.4. Ion Beam
10.3.5. Others
10.4. North America Global Linear Particle Accelerators Market Value Forecast, by End-user, 2018–2030
10.4.1. Hospitals
10.4.2. Ambulatory Care Centers
10.4.3. Research Centers
10.5. North America Global Linear Particle Accelerators Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Global Linear Particle Accelerators Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By End-user
10.6.3. By Country
11. Europe Global Linear Particle Accelerators Market Analysis and Forecast
11.1. Introduction
11.2. Europe Global Linear Particle Accelerators Market Value and Volume Forecast, by Type, 2018–2030
11.2.1. Low-energy Machine
11.2.2. Medium-energy Machine
11.2.3. High-energy Machine
11.3. Europe Global Linear Particle Accelerators Market Value and Volume Forecast, by Product Type, 2018–2030
11.3.1. X-Ray
11.3.2. Electron
11.3.3. Proton
11.3.4. Ion Beam
11.3.5. Others
11.4. Europe Global Linear Particle Accelerators Market Value Forecast, by End-user, 2018–2030
11.4.1. Hospitals
11.4.2. Ambulatory Care Centers
11.4.3. Research Centers
11.5. Europe Global Linear Particle Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Global Linear Particle Accelerators Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Asia Pacific Global Linear Particle Accelerators Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Global Linear Particle Accelerators Market Value and Volume Forecast, by Type, 2018–2030
12.2.1. Low-energy Machine
12.2.2. Medium-energy Machine
12.2.3. High-energy Machine
12.3. Asia Pacific Global Linear Particle Accelerators Market Value and Volume Forecast, by Product Type, 2018–2030
12.3.1. X-Ray
12.3.2. Electron
12.3.3. Proton
12.3.4. Ion Beam
12.3.5. Others
12.4. Asia Pacific Global Linear Particle Accelerators Market Value Forecast, by End-user, 2018–2030
12.4.1. Hospitals
12.4.2. Ambulatory Care Centers
12.4.3. Research Centers
12.5. Asia Pacific Global Linear Particle Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Global Linear Particle Accelerators Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Latin America Global Linear Particle Accelerators Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Global Linear Particle Accelerators Market Value and Volume Forecast, by Type, 2018–2030
13.2.1. Low-energy Machine
13.2.2. Medium-energy Machine
13.2.3. High-energy Machine
13.3. Latin America Global Linear Particle Accelerators Market Value and Volume Forecast, by Product Type, 2018–2030
13.3.1. X-Ray
13.3.2. Electron
13.3.3. Proton
13.3.4. Ion Beam
13.3.5. Others
13.4. Latin America Global Linear Particle Accelerators Market Value Forecast, by End-user, 2018–2030
13.4.1. Hospitals
13.4.2. Ambulatory Care Centers
13.4.3. Research Centers
13.5. Latin America Global Linear Particle Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Global Linear Particle Accelerators Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Middle East & Africa Global Linear Particle Accelerators Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Global Linear Particle Accelerators Market Value and Volume Forecast, by Type, 2018–2030
14.2.1. Low-energy Machine
14.2.2. Medium-energy Machine
14.2.3. High-energy Machine
14.3. Middle East & Africa Global Linear Particle Accelerators Market Value and Volume Forecast, by Product Type, 2018–2030
14.3.1. X-Ray
14.3.2. Electron
14.3.3. Proton
14.3.4. Ion Beam
14.3.5. Others
14.4. Middle East & Africa Global Linear Particle Accelerators Market Value Forecast, by End-user, 2018–2030
14.4.1. Hospitals
14.4.2. Ambulatory Care Centers
14.4.3. Research Centers
14.5. Middle East & Africa Global Linear Particle Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Global Linear Particle Accelerators Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By End-user
14.6.3. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Global Linear Particle Accelerators Market Position Analysis, by Company, 2019
15.3. Company Profiles
15.3.1. Varian Medical Systems, Inc.
15.3.1.1. Company Description
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. Elekta AB
15.3.2.1. Company Description
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Accuray Incorporated
15.3.3.1. Company Description
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. Shinva Medical Instrument Co., Ltd.
15.3.4.1. Company Description
15.3.4.2. Business Overview
15.3.4.3. Strategic Overview
15.3.4.4. Financial Overview
15.3.4.5. SWOT Analysis
15.3.5. Viewray Medical Technologies Inc.
15.3.5.1. Company Description
15.3.5.2. Business Overview
15.3.5.3. Strategic Overview
15.3.5.4. SWOT Analysis